These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5442030)

  • 1. Some studies on the effects of dihydrofolate reductase inhibitors.
    Gitteridge WE; Trigg PI
    Trans R Soc Trop Med Hyg; 1970; 64(1):12. PubMed ID: 5442030
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new cytochemical method for the study of the tetrahydrofolatereductase activity in Plasmodium berghei: analysis of the effect of specific inhibitors].
    Gerzeli G; Polver Pde P
    Riv Parassitol; 1969 Mar; 30(1):19-26. PubMed ID: 5405877
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of pyrimethamine and related drugs against Plasmodium knowlesi in vitr.
    Gutteridge WE; Trigg PI
    Parasitology; 1971 Jun; 62(3):431-44. PubMed ID: 4997058
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmodium knowlesi: in vitro evaluation of antimalarial activity of folic acid inhibitors.
    McCormick GJ; Canfield CJ; Willet GP
    Exp Parasitol; 1971 Aug; 30(1):88-93. PubMed ID: 5316583
    [No Abstract]   [Full Text] [Related]  

  • 5. Activities of trimethoprim against infections with pyrimethamine susceptible and resistant strains of Plasmodium cynomolgi.
    Schmidt LH; Harrison J; Ellison R; Worcester P
    Proc Soc Exp Biol Med; 1969 May; 131(1):294-7. PubMed ID: 4976952
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
    Ferone R; Burchall JJ; Hitchings GH
    Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
    Hekmat-Nejad M; Rathod PK
    Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei.
    Ferone R
    J Biol Chem; 1970 Feb; 245(4):850-4. PubMed ID: 5418106
    [No Abstract]   [Full Text] [Related]  

  • 9. Trimethoprim effect on Plasmodium gallinaceum oocysts.
    Terzakis JA
    J Parasitol; 1971 Oct; 57(5):997. PubMed ID: 5167380
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative studies of dihydrofolate reductase.
    Burchall JJ
    Postgrad Med J; 1969 Nov; 45():Suppl:29-32. PubMed ID: 5361306
    [No Abstract]   [Full Text] [Related]  

  • 11. QSAR using evolved neural networks for the inhibition of mutant PfDHFR by pyrimethamine derivatives.
    Hecht D; Cheung M; Fogel GB
    Biosystems; 2008 Apr; 92(1):10-5. PubMed ID: 18160210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dihydrofolate reductases from Toxoplasma gondii, Pneumocystis carinii, and rat liver by rotationally restricted analogues of pyrimethamine and metoprine.
    Rosowsky A; Queener SF; Cody V
    Drug Des Discov; 1999 Jul; 16(1):25-40. PubMed ID: 10466054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species.
    Irungu B; Kiboi D; Langat B; Rukunga G; Wittlin S; Nzila A
    Exp Parasitol; 2009 Oct; 123(2):118-21. PubMed ID: 19527714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
    McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
    J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
    Alifrangis M; Lemnge MM; Rønn AM; Segeja MD; Magesa SM; Khalil IF; Bygbjerg IC
    Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase.
    Nichol CA; Cavallito JC; Woolley JL; Sigel CW
    Cancer Treat Rep; 1977 Jul; 61(4):559-64. PubMed ID: 301777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
    Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
    J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fragility of the X chromosome and inhibition of dihydrofolate reductase. Comparison of the effects of 2 antibiotics: trimethoprim and pyrimethamine].
    Calva-Mercado MP; Maunoury C; Rethoré MO; Lejeune J
    Ann Genet; 1983; 26(3):147-9. PubMed ID: 6606377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates.
    Eldin de Pecoulas P; Abdallah B; Dje MK; Basco LK; le Bras J; Mazabraud A
    Mol Cell Probes; 1995 Dec; 9(6):391-7. PubMed ID: 8808309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.